Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 13 Oct 2026 for Ocular Therapeutix, INC, €78k. Read the official filing
Filing timeline
BuySaleTodd Anderman
Insider track record
Disclosed buys
0
Disclosed sells
2
Signal history
No signal scores available.
Todd Anderman: trading record in brief
All filings by Todd Anderman on record concern Ocular Therapeutix, Inc. Between 7 October 2024 and 8 October 2026, the trades on record add up to 4 filings.
On the market, this insider has only sold: 2 sales, €196k in total. Other entries cover 2 share grants. So far in 2026, the count stands at no purchases and 1 sale.
Most recently, on 13 October 2026, the filings show an open-market sale worth €78k in Ocular Therapeutix, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Todd Anderman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
11,984 shares@ US$7.29Common StockSEC:0001104659-26-115551:0
64,900 shares0Common StockSEC:0001104659-26-001296:0
11,132 shares@ US$12.34100.0% of flowCommon StockSEC:0001104659-25-098706:0
98,700 shares0Common StockSEC:0001104659-24-107392:0
4 of 4 declarations
